Lp-PLA2-IN-2
Modify Date: 2024-01-10 17:14:03
Lp-PLA2-IN-2 structure
|
Common Name | Lp-PLA2-IN-2 | ||
|---|---|---|---|---|
| CAS Number | 2071636-15-0 | Molecular Weight | 394.46 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C19H23FN2O4S | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of Lp-PLA2-IN-2Lp-PLA2-IN-2 is a potent and selective lipoprotein-associated phospholipase A2 (Lp-PLA2) inhibitor, with an IC50 0f 120 nM for recombinant human Lp-PLA2[1]. |
| Name | Lp-PLA2-IN-2 |
|---|
| Description | Lp-PLA2-IN-2 is a potent and selective lipoprotein-associated phospholipase A2 (Lp-PLA2) inhibitor, with an IC50 0f 120 nM for recombinant human Lp-PLA2[1]. |
|---|---|
| Related Catalog | |
| Target |
Lp-PLA2:120 nM (IC50) |
| In Vitro | Lp-PLA2-IN-2 inhibits Human Lp-PLA2 with an IC50 of 62 nM in PED6 assay[1]. |
| In Vivo | Lp-PLA2-IN-2 (1 mg/kg; i.v.) treament in rats shows that the Cl, Vss and t1/2 values are 67 mL/min/kg, 1.2 L/kg, and 0.34 hours, respectively[1]. Animal Model: Male Han Wistar rats (250-300 g)[1] Dosage: 1 mg/kg Administration: i.v. (Pharmacokinetic Analysis) Result: The Cl, Vss and t1/2 values were 67 mL/min/kg, 1.2 L/kg, and 0.34 hours, respectively. |
| References |
| Molecular Formula | C19H23FN2O4S |
|---|---|
| Molecular Weight | 394.46 |
| Hazard Codes | Xi |
|---|